Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1965 1
1967 3
1968 1
1969 1
1970 1
1971 5
1972 2
1974 3
1975 7
1976 8
1977 1
1978 7
1979 9
1980 8
1981 6
1982 5
1983 6
1984 4
1985 6
1986 6
1987 9
1988 4
1989 9
1990 15
1991 10
1992 16
1993 13
1994 14
1995 17
1996 15
1997 25
1998 16
1999 15
2000 18
2001 17
2002 22
2003 20
2004 34
2005 40
2006 35
2007 30
2008 35
2009 40
2010 37
2011 32
2012 53
2013 51
2014 51
2015 53
2016 59
2017 44
2018 53
2019 70
2020 82
2021 98
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

1,138 results
Results by year
Filters applied: . Clear all
Page 1
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Peled JU, et al. Among authors: shah gl. N Engl J Med. 2020 Feb 27;382(9):822-834. doi: 10.1056/NEJMoa1900623. N Engl J Med. 2020. PMID: 32101664 Free PMC article.
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.
Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, Khan Z, Obla A, Dutta J, van Bakel H, Aberg J, García-Sastre A, Shah G, Hohl T, Papanicolaou G, Perales MA, Sepkowitz K, Babady NE, Kamboj M. Aydillo T, et al. Among authors: shah g. N Engl J Med. 2020 Dec 24;383(26):2586-2588. doi: 10.1056/NEJMc2031670. Epub 2020 Dec 1. N Engl J Med. 2020. PMID: 33259154 Free PMC article. No abstract available.
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Sharma A, Bhatt NS, St Martin A, Abid MB, Bloomquist J, Chemaly RF, Dandoy C, Gauthier J, Gowda L, Perales MA, Seropian S, Shaw BE, Tuschl EE, Zeidan AM, Riches ML, Shah GL. Sharma A, et al. Among authors: shah gl. Lancet Haematol. 2021 Mar;8(3):e185-e193. doi: 10.1016/S2352-3026(20)30429-4. Epub 2021 Jan 19. Lancet Haematol. 2021. PMID: 33482113 Free PMC article.
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation.
Shah GL, DeWolf S, Lee YJ, Tamari R, Dahi PB, Lavery JA, Ruiz J, Devlin SM, Cho C, Peled JU, Politikos I, Scordo M, Babady NE, Jain T, Vardhana S, Daniyan A, Sauter CS, Barker JN, Giralt SA, Goss C, Maslak P, Hohl TM, Kamboj M, Ramanathan L, van den Brink MR, Papadopoulos E, Papanicolaou G, Perales MA. Shah GL, et al. J Clin Invest. 2020 Dec 1;130(12):6656-6667. doi: 10.1172/JCI141777. J Clin Invest. 2020. PMID: 32897885 Free PMC article. Clinical Trial.
Correspondence.
Rao RC, Shah GK. Rao RC, et al. Among authors: shah gk. Retina. 2020 Feb;40(2):e5. doi: 10.1097/IAE.0000000000002739. Retina. 2020. PMID: 31972812 No abstract available.
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.
Sermer D, Batlevi C, Palomba ML, Shah G, Lin RJ, Perales MA, Scordo M, Dahi P, Pennisi M, Afuye A, Silverberg ML, Ho C, Flynn J, Devlin S, Caron P, Hamilton A, Hamlin P, Horwitz S, Joffe E, Kumar A, Matasar M, Noy A, Owens C, Moskowitz A, Straus D, von Keudell G, Rodriguez-Rivera I, Falchi L, Zelenetz A, Yahalom J, Younes A, Sauter C. Sermer D, et al. Among authors: shah g. Blood Adv. 2020 Oct 13;4(19):4669-4678. doi: 10.1182/bloodadvances.2020002118. Blood Adv. 2020. PMID: 33002134 Free PMC article.
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM, Omuro A. Morris PG, et al. Among authors: shah g. J Clin Oncol. 2013 Nov 1;31(31):3971-9. doi: 10.1200/JCO.2013.50.4910. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101038 Free PMC article. Clinical Trial.
Checkpoint inhibition in lymphoma.
Shah GL, Moskowitz CH. Shah GL, et al. Clin Adv Hematol Oncol. 2018 Jan;16(1):45-55. Clin Adv Hematol Oncol. 2018. PMID: 29741505 Review.
1,138 results